Literature DB >> 29030428

A retractable lid in lecithin:cholesterol acyltransferase provides a structural mechanism for activation by apolipoprotein A-I.

Kelly A Manthei1, Joomi Ahn2, Alisa Glukhova1, Wenmin Yuan3, Christopher Larkin2, Taylor D Manett1, Louise Chang1, James A Shayman4, Milton J Axley2, Anna Schwendeman3, John J G Tesmer5.   

Abstract

Lecithin:cholesterol acyltransferase (LCAT) plays a key role in reverse cholesterol transport by transferring an acyl group from phosphatidylcholine to cholesterol, promoting the maturation of high-density lipoproteins (HDL) from discoidal to spherical particles. LCAT is activated through an unknown mechanism by apolipoprotein A-I (apoA-I) and other mimetic peptides that form a belt around HDL. Here, we report the crystal structure of LCAT with an extended lid that blocks access to the active site, consistent with an inactive conformation. Residues Thr-123 and Phe-382 in the catalytic domain form a latch-like interaction with hydrophobic residues in the lid. Because these residues are mutated in genetic disease, lid displacement was hypothesized to be an important feature of apoA-I activation. Functional studies of site-directed mutants revealed that loss of latch interactions or the entire lid enhanced activity against soluble ester substrates, and hydrogen-deuterium exchange (HDX) mass spectrometry revealed that the LCAT lid is extremely dynamic in solution. Upon addition of a covalent inhibitor that mimics one of the reaction intermediates, there is an overall decrease in HDX in the lid and adjacent regions of the protein, consistent with ordering. These data suggest a model wherein the active site of LCAT is shielded from soluble substrates by a dynamic lid until it interacts with HDL to allow transesterification to proceed.
© 2017 by The American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  HDX MS; acyltransferase; apolipoprotein; cholesterol; conformational change; crystallography; high-density lipoprotein (HDL); inhibitor; lecithin; structural biology

Mesh:

Substances:

Year:  2017        PMID: 29030428      PMCID: PMC5724016          DOI: 10.1074/jbc.M117.802736

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  62 in total

1.  The utility of hydrogen/deuterium exchange mass spectrometry in biopharmaceutical comparability studies.

Authors:  Damian Houde; Steven A Berkowitz; John R Engen
Journal:  J Pharm Sci       Date:  2010-12-29       Impact factor: 3.534

2.  Database searching and accounting of multiplexed precursor and product ion spectra from the data independent analysis of simple and complex peptide mixtures.

Authors:  Guo-Zhong Li; Johannes P C Vissers; Jeffrey C Silva; Dan Golick; Marc V Gorenstein; Scott J Geromanos
Journal:  Proteomics       Date:  2009-03       Impact factor: 3.984

3.  The open conformation of a Pseudomonas lipase.

Authors:  J D Schrag; Y Li; M Cygler; D Lang; T Burgdorf; H J Hecht; R Schmid; D Schomburg; T J Rydel; J D Oliver; L C Strickland; C M Dunaway; S B Larson; J Day; A McPherson
Journal:  Structure       Date:  1997-02-15       Impact factor: 5.006

4.  Molecular genetic study of Finns with hypoalphalipoproteinemia and hyperalphalipoproteinemia: a novel Gly230 Arg mutation (LCAT[Fin]) of lecithin:cholesterol acyltransferase (LCAT) accounts for 5% of cases with very low serum HDL cholesterol levels.

Authors:  H E Miettinen; H Gylling; J Tenhunen; J Virtamo; M Jauhiainen; J K Huttunen; I Kantola; T A Miettinen; K Kontula
Journal:  Arterioscler Thromb Vasc Biol       Date:  1998-04       Impact factor: 8.311

5.  Apolipoprotein E is the major physiological activator of lecithin-cholesterol acyltransferase (LCAT) on apolipoprotein B lipoproteins.

Authors:  Yue Zhao; Fayanne E Thorngate; Karl H Weisgraber; David L Williams; John S Parks
Journal:  Biochemistry       Date:  2005-01-25       Impact factor: 3.162

6.  The high-resolution crystal structure of human LCAT.

Authors:  Derek E Piper; William G Romanow; Ruwanthi N Gunawardane; Preston Fordstrom; Stephanie Masterman; Oscar Pan; Stephen T Thibault; Richard Zhang; David Meininger; Margrit Schwarz; Zhulun Wang; Chadwick King; Mingyue Zhou; Nigel P C Walker
Journal:  J Lipid Res       Date:  2015-07-20       Impact factor: 5.922

7.  Features and development of Coot.

Authors:  P Emsley; B Lohkamp; W G Scott; K Cowtan
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-03-24

8.  In vitro expression of structural defects in the lecithin-cholesterol acyltransferase gene.

Authors:  H G Klein; N Duverger; J J Albers; S Marcovina; H B Brewer; S Santamarina-Fojo
Journal:  J Biol Chem       Date:  1995-04-21       Impact factor: 5.157

9.  A Systematic Investigation of Structure/Function Requirements for the Apolipoprotein A-I/Lecithin Cholesterol Acyltransferase Interaction Loop of High-density Lipoprotein.

Authors:  Xiaodong Gu; Zhiping Wu; Ying Huang; Matthew A Wagner; Camelia Baleanu-Gogonea; Ryan A Mehl; Jennifer A Buffa; Anthony J DiDonato; Leah B Hazen; Paul L Fox; Valentin Gogonea; John S Parks; Joseph A DiDonato; Stanley L Hazen
Journal:  J Biol Chem       Date:  2016-01-21       Impact factor: 5.157

10.  Combined monogenic hypercholesterolemia and hypoalphalipoproteinemia caused by mutations in LDL-R and LCAT genes.

Authors:  Livia Pisciotta; Laura Calabresi; Graziana Lupattelli; Donatella Siepi; Massimo Raffaele Mannarino; Elsa Moleri; Antonella Bellocchio; Alfredo Cantafora; Patrizia Tarugi; Sebastiano Calandra; Stefano Bertolini
Journal:  Atherosclerosis       Date:  2005-03-31       Impact factor: 5.162

View more
  14 in total

1.  Plasma lipoprotein-X quantification on filipin-stained gels: monitoring recombinant LCAT treatment ex vivo.

Authors:  Lita A Freeman; Robert D Shamburek; Maureen L Sampson; Edward B Neufeld; Masaki Sato; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Lipid Res       Date:  2019-02-26       Impact factor: 5.922

2.  LCAT Enzyme Replacement Therapy Reduces LpX and Improves Kidney Function in a Mouse Model of Familial LCAT Deficiency.

Authors:  Boris L Vaisman; Edward B Neufeld; Lita A Freeman; Scott M Gordon; Maureen L Sampson; Milton Pryor; Emily Hillman; Milton J Axley; Sotirios K Karathanasis; Alan T Remaley
Journal:  J Pharmacol Exp Ther       Date:  2018-12-18       Impact factor: 4.030

3.  Molecular basis for activation of lecithin:cholesterol acyltransferase by a compound that increases HDL cholesterol.

Authors:  Kelly A Manthei; Shyh-Ming Yang; Bolormaa Baljinnyam; Louise Chang; Alisa Glukhova; Wenmin Yuan; Lita A Freeman; David J Maloney; Anna Schwendeman; Alan T Remaley; Ajit Jadhav; John Jg Tesmer
Journal:  Elife       Date:  2018-11-27       Impact factor: 8.140

4.  Structural Basis of Lysosomal Phospholipase A2 Inhibition by Zn2.

Authors:  Renee A Bouley; Vania Hinkovska-Galcheva; James A Shayman; John J G Tesmer
Journal:  Biochemistry       Date:  2019-03-13       Impact factor: 3.162

5.  Effects of Disease-Causing Mutations on the Conformation of Human Apolipoprotein A-I in Model Lipoproteins.

Authors:  Christopher J Wilson; Madhurima Das; Shobini Jayaraman; Olga Gursky; John R Engen
Journal:  Biochemistry       Date:  2018-07-13       Impact factor: 3.162

6.  Interaction of lecithin:cholesterol acyltransferase with lipid surfaces and apolipoprotein A-I-derived peptides.

Authors:  Marco G Casteleijn; Petteri Parkkila; Tapani Viitala; Artturi Koivuniemi
Journal:  J Lipid Res       Date:  2018-02-08       Impact factor: 5.922

7.  Determinants of pH profile and acyl chain selectivity in lysosomal phospholipase A2.

Authors:  Vania Hinkovska-Galcheva; Robert Kelly; Kelly A Manthei; Renee Bouley; Wenmin Yuan; Anna Schwendeman; John J G Tesmer; James A Shayman
Journal:  J Lipid Res       Date:  2018-05-03       Impact factor: 5.922

8.  Lecithin:cholesterol acyltransferase: symposium on 50 years of biomedical research from its discovery to latest findings.

Authors:  Kaare R Norum; Alan T Remaley; Helena E Miettinen; Erik H Strøm; Bruno E P Balbo; Carlos A T L Sampaio; Ingrid Wiig; Jan Albert Kuivenhoven; Laura Calabresi; John J Tesmer; Mingyue Zhou; Dominic S Ng; Bjørn Skeie; Sotirios K Karathanasis; Kelly A Manthei; Kjetil Retterstøl
Journal:  J Lipid Res       Date:  2020-06-01       Impact factor: 5.922

9.  Structural analysis of lecithin:cholesterol acyltransferase bound to high density lipoprotein particles.

Authors:  Kelly A Manthei; Dhabaleswar Patra; Christopher J Wilson; Maria V Fawaz; Lolita Piersimoni; Jenny Capua Shenkar; Wenmin Yuan; Philip C Andrews; John R Engen; Anna Schwendeman; Melanie D Ohi; John J G Tesmer
Journal:  Commun Biol       Date:  2020-01-15

10.  Single nucleotide polymorphisms in LCAT may contribute to dyslipidaemia in HIV-infected individuals on HAART in a Ghanaian population.

Authors:  Simon Bannison Bani; Kwabena Owusu Danquah; Christian Obirikorang; William K B A Owiredu; Lawrence Quaye; Edmund Muonir Der; Emmanuel Acheampong; Yussif Adams; Peter Paul M Dapare; Moses Banyeh; Enoch Odame Anto; Samuel Asamoah Sakyi
Journal:  Sci Rep       Date:  2020-11-10       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.